Vaxess is a Massachusetts-based life sciences company that designs, develops and supplies shelf-stable MIMIX skin patches for the pharmaceutical industry.
$9M
Apr 08, 2025
-
Edgewise Therapeutics is a biopharmaceutical company that develops and commercializes small molecule therapeutics to treat musculoskeletal diseases.
$200M
Apr 02, 2025
-
Vivace is a pharmaceutical company that develops and commercializes small molecule drugs for the treatment of cancer diseases.
$35M
Mar 11, 2025
-
Curevo is a Washington-based biotechnology company that researches and develops vaccines for the treatment of infectious diseases.
$110M
Mar 05, 2025
-
Frequently Asked Questions about RA Capital
What is RA Capital investing in?
RA Capital has invested in 374 companies including Imbria Pharmaceuticals, Vaxess and Edgewise Therapeutics
What company did RA Capital invest in?
RA Capital invested in a total 374 companies including Imbria Pharmaceuticals, Vaxess and Edgewise Therapeutics
What are the top 5 investments by RA Capital?
The top companies in which RA Capital invested are Imbria Pharmaceuticals, Vaxess, Edgewise Therapeutics, Vivace and Curevo
